Back

Prognostic impact of LV GLS response in Fabry patients on enzyme replacement therapy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Fabry disease Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hao Chih Chang

Taipei Veterans General Hospital, Taipei (Taiwan)

7 More presentations in this session

Presentation thumbnail
Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study
Doctor Y. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
FollowME Fabry Pathfinders real-world registry in Spain and Portugal: cardiac and renal outcomes with migalastat in patients with Fabry disease
Professor O. Azevedo (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Apical hypertrophic cardiomyopathy: could it be Fabry?
Doctor S. Findlay (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Prevalence of pseudo-delta wave in Anderson-Fabry disease and challenges in differentiating from ventricular pre-excitation
Doctor S. Serratore (Catanzaro, IT)
Abstract Slides Video
Presentation thumbnail
Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study
Doctor E. Martins (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Fabry disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study
thumbnail
Congress Presentation
Imaging predictors of adverse prognosis in fabry disease cardiomyopathy: a systematic review and meta-analysis
thumbnail
Congress Presentation
Cardiac magnetic resonance findings in Fabry disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources